Invasive lobular carcinoma stable for 4.5 years in a postmenopausal woman user of hormone therapy for 25 years

References

• Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 2003;289:1421–4
   PubMed Web of Science ®Google Scholar
• Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004;6:R149–56
   PubMed Web of Science ®Google Scholar
• Fortunato L, Mascaro A, Poccia I, et al. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period. Ann Surg Oncol 2012;19:1107–14
   PubMedGoogle Scholar
• Colleoni M, Rotmensz N, Maisonneuve P, et al. Outcome of special types of luminal breast cancer. Ann Oncol 2012;23:1428–36
   PubMed Web of Science ®Google Scholar
• Nagao T, Kinoshita T, Hojo T, et al. The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics. Breast 2012;21:289–95
   PubMedGoogle Scholar
• Li CI, Malone KE, Porter PL, et al. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 2003;289:3254–63
   PubMed Web of Science ®Google Scholar
• Reeves GK, Beral V, Green J, et al. Million Women Study Collaborators. Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol 2006;7:910–8
   PubMed Web of Science ®Google Scholar
• Kim SH, Cha ES, Park CS, et al. Imaging features of invasive lobular carcinoma: comparison with invasive ductal carcinoma. Jpn J Radiol 2011;29:475–82
   PubMedGoogle Scholar
• Dedes KJ, Fink D. Clinical presentation and surgical management of invasive lobular carcinoma of the breast. Breast Dis 2008;30:31–7
   PubMedGoogle Scholar
• Lopez JK, Bassett LW. Invasive lobular carcinoma of the breast: spectrum of mammographic, US, and MR imaging findings. Radiographics 2009;29:165–76
   PubMedGoogle Scholar
• Krecke KN, Gisvold JJ. Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol 1993;161:957–60
   PubMedGoogle Scholar
• Brem RF, Ioffe M, Rapelyea JA, et al. Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging. AJR Am J Roentgenol 2009;192:379–83
   PubMedGoogle Scholar
• Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004;233:830–49
   PubMed Web of Science ®Google Scholar
• Stivalet A, Luciani A, Pigneur F, et al. Invasive lobular carcinoma of the breast: MRI pathological correlation following bilateral total mastectomy. Acta Radiol 2012;53:367–75
   PubMedGoogle Scholar
• Iorfida M, Maiorano E, Orvieto E, et al. Invasive lobular breast cancer: subtypes and outcome. Breast Cancer Res Treat 2012;133:713–23
   PubMedGoogle Scholar
• Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011;22:1736–47
   PubMed Web of Science ®Google Scholar
• McTiernan A, Martin CF, Peck JD, et al. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial. J Natl Cancer Inst 2005;97:1366–76
   PubMed Web of Science ®Google Scholar
• Kavanagh AM, Mitchell H, Giles GG. Hormone replacement therapy and accuracy of mammographic screening. Lancet 2000;355:270–4
   PubMedGoogle Scholar
• Mann RM, Hoogeveen YL, Blickman JG, Boetes C. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat 2008;107:1–14
   PubMedGoogle Scholar
• Heil J, Buehler A, Golatta M, et al. Do patients with invasive lobular breast cancer benefit in terms of adequate change in surgical therapy from a supplementary preoperative breast MRI? Ann Oncol 2012;23:98–104
   PubMedGoogle Scholar
• Morrow M, Keeney K, Scholtens D, et al. Selecting patients for breast-conserving therapy: the importance of lobular histology. Cancer 2006;106:2563–8
   PubMed Web of Science ®Google Scholar
• Singletary SE, Patel-Parekh L, Bland KI. Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Database. Ann Surg 2005;242:281–9
   PubMedGoogle Scholar
• Chlebowski RT, Anderson GL, Gass M, et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 2010;304:1684–92
   PubMed Web of Science ®Google Scholar
• Sener SF, Winchester DJ, Winchester DP, et al. The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival. Am J Surg 2009;197:403–7
   PubMed Web of Science ®Google Scholar
• Sacchini V, Zurrida S, Andreoni G, et al. Pathologic and biological prognostic factors of breast cancers in short- and long-term hormone replacement therapy users. Ann Surg Oncol 2002;9:266–71
   PubMed Web of Science ®Google Scholar
• Aebi S, Sun Z, Braun D, et al. Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX. Ann Oncol 2011;22:1981–7
   PubMed Web of Science ®Google Scholar
• Coates AS, Colleoni M, Goldhirsch A. Is adjuvant chemotherapy useful for women with luminal A breast cancer? J Clin Oncol 2012;30:1260–3
   PubMed Web of Science ®Google Scholar